We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Features Compounding in Farewell Congressional Testimony
Gottlieb Features Compounding in Farewell Congressional Testimony
Outgoing FDA Commissioner Scott Gottlieb highlighted plans for drug compounding enforcement among the agency’s drug priorities in his final testimony before House appropriators on Wednesday.